KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Travere Therapeutics (TVTX) over the last 12 years, with Q3 2025 value amounting to $207000.0.

  • Travere Therapeutics' Exchange Rate Effect fell 5430.46% to $207000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 3572.54%. This contributed to the annual value of -$913000.0 for FY2024, which is 14608.78% down from last year.
  • Per Travere Therapeutics' latest filing, its Exchange Rate Effect stood at $207000.0 for Q3 2025, which was down 5430.46% from $1.9 million recorded in Q2 2025.
  • Over the past 5 years, Travere Therapeutics' Exchange Rate Effect peaked at $1.9 million during Q2 2025, and registered a low of -$1.7 million during Q2 2022.
  • Its 5-year average for Exchange Rate Effect is $141631.6, with a median of $64000.0 in 2021.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first plummeted by 308571.43% in 2022, then skyrocketed by 188807.34% in 2025.
  • Travere Therapeutics' Exchange Rate Effect (Quarter) stood at $1.7 million in 2021, then crashed by 33.66% to $1.1 million in 2022, then rose by 7.89% to $1.2 million in 2023, then tumbled by 178.31% to -$964000.0 in 2024, then soared by 121.47% to $207000.0 in 2025.
  • Its Exchange Rate Effect stands at $207000.0 for Q3 2025, versus $1.9 million for Q2 2025 and $548000.0 for Q1 2025.